<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "3: profitable surgical facilities could limit", fill: "#922724"},
{source: "3: profitable surgical facilities could limit", target: "3: profitability", fill: "#922724"},
{source: "3: profitability", target: "3: focused on growing", fill: "#922724"},
{source: "3: focused on growing", target: "3: costeffective manner", fill: "#922724"},
{source: "3: profitable surgical facilities could limit", target: "4: surgical procedures at", fill: "#522d80"},
{source: "4: surgical procedures at", target: "5: patient base", fill: "#708090"},
{source: "5: patient base", target: "5: administrative", fill: "#708090"},
{source: "5: administrative", target: "5: financial services", fill: "#708090"},
{source: "5: financial services", target: "5: sustain profitability", fill: "#708090"},
{source: "5: patient base", target: "6: facilities may generate losses", fill: "#3b3c36"},
{source: "6: facilities may generate losses", target: "6: margins than", fill: "#3b3c36"},
{source: "6: margins than", target: "6: established facilities", fill: "#3b3c36"},
{source: "6: established facilities", target: "6: investment", fill: "#3b3c36"},
{source: "6: facilities may generate losses", target: "11: acquisition", fill: "#ff7e00"},
{source: "11: acquisition", target: "11: development", fill: "#ff7e00"},
{source: "11: development", target: "11: from cash generated from", fill: "#ff7e00"},
{source: "11: from cash generated from", target: "11: operations", fill: "#ff7e00"},
{source: "11: operations", target: "11: amounts borrowed", fill: "#ff7e00"},
{source: "11: amounts borrowed", target: "11: facility", fill: "#ff7e00"},
{source: "11: acquisition", target: "23: Competitors ", fill: "#a52a2a"},
{source: "23: Competitors ", target: "23: with substantially greater resources may", fill: "#a52a2a"},
{source: "23: with substantially greater resources may", target: "23: surgical facilities", fill: "#a52a2a"},
{source: "23: Competitors ", target: "25: Companies ", fill: "#71a6d2"},
{source: "25: Companies ", target: "25: health care industry segments", fill: "#71a6d2"},
{source: "25: health care industry segments", target: "25: specialties", fill: "#71a6d2"},
{source: "25: specialties", target: "25: medical practices may become competitors", fill: "#71a6d2"},
{source: "25: medical practices may become competitors", target: "25: competitive", fill: "#71a6d2"},
{source: "25: Companies ", target: "32: there often", fill: "#74c365"},
{source: "32: there often", target: "32: alternatives", fill: "#74c365"},
{source: "32: alternatives", target: "32: regulations", fill: "#74c365"},
{source: "32: regulations", target: "32: agreement", fill: "#74c365"},
{source: "32: agreement", target: "32: competitive", fill: "#74c365"},
{source: "32: competitive", target: "32: difficult", fill: "#74c365"},
{source: "32: difficult", target: "32: and or ASCs ", fill: "#74c365"},
{source: "32: and or ASCs ", target: "32: certification", fill: "#74c365"},
{source: "32: there often", target: "33: reimbursement rates", fill: "#f0fff0"},
{source: "33: reimbursement rates", target: "33: surgical procedures as", fill: "#f0fff0"},
{source: "33: surgical procedures as", target: "33: competition", fill: "#f0fff0"},
{source: "33: competition", target: "33: governmental", fill: "#f0fff0"},
{source: "33: governmental", target: "33: private third party", fill: "#f0fff0"},
{source: "33: private third party", target: "33: payor cost containment efforts could reduce", fill: "#f0fff0"},
{source: "33: payor cost containment efforts could reduce", target: "33: revenue profitability", fill: "#f0fff0"},
{source: "33: revenue profitability", target: "33: cash flow", fill: "#f0fff0"},
{source: "33: cash flow", target: "33: Government ", fill: "#f0fff0"},
{source: "33: Government ", target: "33: sponsored health care programs accounted", fill: "#f0fff0"},
{source: "33: sponsored health care programs accounted", target: "33: approximately", fill: "#f0fff0"},
{source: "33: approximately", target: "33: consolidated net revenue", fill: "#f0fff0"},
{source: "33: consolidated net revenue", target: "33: December ", fill: "#f0fff0"},
{source: "33: reimbursement rates", target: "START_HERE", fill: "#f0fff0"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Diversified Financial Services</td>
    </tr>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
    <tr>
      <td>Trading Companies and Distributors</td>
    </tr>
    <tr>
      <td>Housewares and Specialties</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Commercial and Professional Services</td>
    </tr>
    <tr>
      <td>Electronic Equipment and Instruments</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Ease</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Seize</td>
    </tr>
    <tr>
      <td>Comment</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Consult</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Riot</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profit_(economics)">Profit (economics)</a></td>
      <td>An economic profit is the difference between the revenue a  commercial entity has received from its outputs and the opportunity costs of its inputs. It equals to total revenue minus total cost, including both explicit and implicit costs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitability_analysis">Profitability analysis</a></td>
      <td>In cost accounting, profitability analysis is an analysis of the profitability of an organisation's output. Output of an organisation can be grouped into products, customers, locations, channels and/or transactions.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitability_index">Profitability index</a></td>
      <td>Profitability index (PI), also known as profit investment ratio (PIR) and value investment ratio (VIR), is the ratio of payoff to investment of a proposed project. It is a useful tool for ranking projects because it allows you to quantify the amount of value created per unit of investment.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_Profitability_Analysis">Customer Profitability Analysis</a></td>
      <td>Customer Profitability Analysis (in short CPA) is a management accounting and a credit underwriting method, allowing businesses and lenders to determine the profitability of each customer or segments of customers, by attributing profits and costs to each customer separately. CPA can be applied at the individual customer level (more time consuming, but providing a better understanding of business situation) or at the level of customer aggregates / groups (e.g.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitable_growth">Profitable growth</a></td>
      <td>Profitable Growth is the combination of profitability and growth, more precisely the combination of Economic Profitability and Growth of Free cash flows. Profitable growth is aimed at seducing the financial community; it emerged in the early 80s when shareholder value creation became firms’ main objective.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_profitability">Customer profitability</a></td>
      <td>Customer profitability (CP) is the profit the firm makes from serving a customer or customer group over a specified period of time, specifically the difference between the revenues earned from and the costs associated with the customer relationship in a specified period. According to Philip Kotler,"a profitable customer is a person, household or a company that overtime, yields a revenue stream that exceeds by an acceptable amount the company's cost stream of attracting, selling and servicing the customer."\nCalculating customer profit is an important step in understanding which customer relationships are better than others.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Small_Is_Profitable">Small Is Profitable</a></td>
      <td>Small Is Profitable: The Hidden Economic Benefits of Making Electrical Resources the Right Size is a 2002 book by energy analyst Amory Lovins and others.  The book describes 207 ways in which the size of "electrical resources"—devices that make, save, or store electricity—affects their economic value.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/SAP_ERP">SAP ERP</a></td>
      <td>SAP ERP is an enterprise resource planning software developed by the German company SAP SE. SAP ERP incorporates the key business functions of an organization. The latest version of SAP ERP (V.6.0) was made available in 2006.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Porter's_five_forces_analysis">Porter's five forces analysis</a></td>
      <td>Porter's Five Forces Framework is a method of analysing the operating environment of a competition of a business. It draws from industrial organization (IO) economics to derive five forces that determine the competitive intensity and, therefore, the attractiveness (or lack thereof) of an industry in terms of its profitability.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Return_on_equity">Return on equity</a></td>
      <td>The return on equity (ROE) is a measure of the profitability of a business in relation to the equity. Because shareholder's equity can be calculated by taking all assets and subtracting all liabilities, ROE can also be thought of as a return on assets minus liabilities.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Facility_management">Facility management</a></td>
      <td>Facility management, or facilities management, (FM) is a professional management discipline focused on the efficient and effective delivery of logistics and other support services related to real property, it encompasses multiple disciplines to ensure functionality, comfort, safety and efficiency of the built environment by integrating people, place, process and technology, as defined by the International Organization for Standardization (ISO). The profession is certified through Global Facility Management Association (Global FM) member organizations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_(mathematics)">Operation (mathematics)</a></td>
      <td>In mathematics, an operation is a function which takes zero or more input values (called operands) to a well-defined output value. The number of operands (also known as arguments) is the arity of the operation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Facility_ID">Facility ID</a></td>
      <td>The facility ID number, also called a FIN or facility identifier, is a unique integer number of one to six digits, assigned by the U.S. Federal Communications Commission (FCC) Media Bureau to each broadcast station in the FCC Consolidated Database System (CDBS) and Licensing and Management System (LMS) databases, among others.\nBecause CDBS includes information about foreign stations which are notified to the U.S. under the terms of international frequency coordination agreements, FINs are also assigned to affected foreign stations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Health_facility">Health facility</a></td>
      <td>A health facility is, in general, any location where healthcare is provided. Health facilities range from small clinics and doctor's offices to urgent care centers and large hospitals with elaborate emergency rooms and trauma centers.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Facility_location">Facility location</a></td>
      <td>Facility location is a name given to several different problems in computer science and in game theory:</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Mint_(facility)">Mint (facility)</a></td>
      <td>A mint is an industrial facility which manufactures coins that can be used as currency.\nThe history of mints correlates closely with the history of coins.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Federal_Reserve">Federal Reserve</a></td>
      <td>The Federal Reserve System (also known as the Federal Reserve or simply the Fed) is the central banking system of the United States of America. It was created on December 23, 1913, with the enactment of the Federal Reserve Act, after a series of financial panics (particularly the panic of 1907) led to the desire for central control of the monetary system in order to alleviate financial crises.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Pine_Gap">Pine Gap</a></td>
      <td>Pine Gap is the commonly used name for a satellite surveillance base and Australian Earth station approximately 18 kilometres (11 mi) south-west of the town of Alice Springs, Northern Territory in the centre of Australia. It is jointly operated by Australia and the United States, and since 1988 it has been officially called the Joint Defence Facility Pine Gap (JDFPG); previously, it was known as Joint Defence Space Research Facility.The station is partly run by the US Central Intelligence Agency (CIA), US National Security Agency (NSA), and US National Reconnaissance Office (NRO) and is a key contributor to the NSA's global interception effort, which included the ECHELON program.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Outpatient_surgery">Outpatient surgery</a></td>
      <td>Outpatient surgery, also known as ambulatory surgery, day surgery, day case surgery, or same-day surgery, is surgery that does not require an overnight hospital stay. The term “outpatient” arises from the fact that surgery patients may enter and leave the facility on the same day.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Health_Insurance_Portability_and_Accountability_Act">Health Insurance Portability and Accountability Act</a></td>
      <td>The Health Insurance Portability and Accountability Act of 1996 (HIPAA or the Kennedy–Kassebaum Act) is a United States federal statute enacted by the 104th United States Congress and signed into law by President Bill Clinton on August 21, 1996. It modernized the flow of healthcare information, stipulates how personally identifiable information maintained by the healthcare and healthcare insurance industries should be protected from fraud and theft, and addressed some limitations on healthcare insurance coverage.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation">Regulation</a></td>
      <td>Regulation is the management of complex systems according to a set of rules and trends. In systems theory, these types of rules exist in various fields of biology and society, but the term has slightly different meanings according to context.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation_of_therapeutic_goods">Regulation of therapeutic goods</a></td>
      <td>The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Formula_One_regulations">Formula One regulations</a></td>
      <td>The numerous Formula One regulations, made and enforced by the FIA and later the FISA, have changed dramatically since the first Formula One World Championship in 1950. This article covers the current state of F1 technical and sporting regulations, as well as the history of the technical regulations since 1950.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/New_York_Codes,_Rules_and_Regulations">New York Codes, Rules and Regulations</a></td>
      <td>The New York Codes, Rules and Regulations (NYCRR) contains New York state rules and regulations. The NYCRR is officially compiled by the New York State Department of State's Division of Administrative Rules.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>NOVAMED INC      Item 1A Risk Factors            The <font color="blue">following factors should</font> be considered in evaluating our company     and  our  business</td>
    </tr>
    <tr>
      <td>These <font color="blue">factors may</font> have a <font color="blue"><font color="blue">significant</font> impact on</font> our     business, operating results and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td><font color="blue">Risks Relating </font>to Our Business         Our failure to operate, acquire or develop a sufficient number of     <font color="blue">profitable <font color="blue">surgical <font color="blue">facilities</font></font> could limit</font> our <font color="blue">profitability</font> and revenue     growth            Our  growth  strategy is <font color="blue">focused on growing</font> our existing ASCs and     acquiring or developing new ASCs in a cost-effective manner</td>
    </tr>
    <tr>
      <td>We may not     experience an increase in <font color="blue"><font color="blue">surgical procedures</font> at</font> our existing or future     ASCs</td>
    </tr>
    <tr>
      <td>We may not be able to achieve the economies of scale and <font color="blue">patient base</font>,     or provide the business, <font color="blue">administrative</font> and <font color="blue">financial services</font> required to     sustain <font color="blue">profitability</font> in our existing and future ASCs</td>
    </tr>
    <tr>
      <td>Newly acquired or     developed <font color="blue"><font color="blue">facilities</font> may generate losses</font> or experience lower operating     <font color="blue">margins than</font> our more <font color="blue">established <font color="blue">facilities</font></font>, or they may not generate     returns that justify our <font color="blue">investment</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">current market</font> for ASC <font color="blue"><font color="blue">acquisition</font>s</font> is very <font color="blue">competitive</font>, and most     <font color="blue">potential targets</font> are <font color="blue">evaluating offers from multiple bidders</font></td>
    </tr>
    <tr>
      <td>This bidding     process  often results in <font color="blue">increased purchase prices</font> and less favorable     <font color="blue">transaction terms</font></td>
    </tr>
    <tr>
      <td>In many instances, we have <font color="blue">dropped out</font> of the bidding     because we thought the price was too high or other <font color="blue">proposed terms</font> were     unacceptable</td>
    </tr>
    <tr>
      <td>We  may not be able to identify <font color="blue">suitable <font color="blue">acquisition</font></font> or     <font color="blue">development</font> targets, <font color="blue">successfully</font> negotiate the <font color="blue">acquisition</font> or <font color="blue">development</font>     of these <font color="blue"><font color="blue">facilities</font> on</font> satisfactory terms, or have the access to adequate     capital to finance these <font color="blue">endeavors</font></td>
    </tr>
    <tr>
      <td>We anticipate that we will fund the <font color="blue">acquisition</font> and <font color="blue">development</font> of     future ASCs <font color="blue">from cash <font color="blue">generated from</font></font> our <font color="blue">operations</font> and <font color="blue">amounts borrowed</font>     under our credit <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>The <font color="blue"><font color="blue">maximum <font color="blue">commitment</font></font> available under</font> our credit     <font color="blue">facility</font> is currently dlra50 million</td>
    </tr>
    <tr>
      <td>Our current credit <font color="blue">facility</font> <font color="blue">expires on</font>     June 30, 2008</td>
    </tr>
    <tr>
      <td><font color="blue">As of March </font>31, 2006, we have available <font color="blue">approximately</font> dlra21     million  remaining  under our credit <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>Given that we intend to     continue  to  finance  our <font color="blue"><font color="blue">acquisition</font>s</font> by using a <font color="blue">combination</font> of cash     <font color="blue">generated from</font> our business <font color="blue">operations</font> and <font color="blue">borrowings under</font> our credit     <font color="blue">facility</font>, we may in the future need to increase our <font color="blue">maximum <font color="blue">commitment</font></font>     available  to  us</td>
    </tr>
    <tr>
      <td>To  the extent we are able to increase our maximum     <font color="blue">commitment</font>, such an increase may not be on terms that are favorable to us or     sufficient for our needs</td>
    </tr>
    <tr>
      <td>In addition, the <font color="blue">continued periodic escalation</font> in     <font color="blue">interest rates</font> has increased our <font color="blue">borrowing costs which</font> have an adverse     effect on our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">borrowing <font color="blue">capacity</font></font> and <font color="blue">higher borrowing</font>     <font color="blue">costs could limit</font> our ability to <font color="blue">successfully</font> implement our <font color="blue">growth strategy</font>,     and <font color="blue">could trigger</font> the need to <font color="blue">procure <font color="blue">additional</font> equity financing</font></td>
    </tr>
    <tr>
      <td>If we are unable to <font color="blue">successfully</font> implement our <font color="blue">growth strategy</font> or     manage our <font color="blue">growth <font color="blue">effectively</font></font>, our business, <font color="blue">financial condition</font> and results     of <font color="blue">operations</font> could be <font color="blue"><font color="blue">adversely</font> affected</font></td>
    </tr>
    <tr>
      <td>We may not <font color="blue">compete <font color="blue">effectively</font> with</font> other companies that have more     resources and experience than us or that may have the ability to influence     our licensure            <font color="blue"><font color="blue">Competitors </font> </font>with  <font color="blue">substantially</font>  greater  financial,  technical,     managerial, marketing and other resources and experience may compete more     <font color="blue">effectively</font>  than  us</td>
    </tr>
    <tr>
      <td>We <font color="blue">compete with</font> other <font color="blue">businesses</font>, including ASC     companies, hospitals, individual <font color="blue">ophthalmologists</font>, other ASCs, <font color="blue">laser vision</font>     <font color="blue">correction</font>  centers,  <font color="blue">eye care clinics</font> and providers of <font color="blue">retail optical</font>     products</td>
    </tr>
    <tr>
      <td><font color="blue">Competitors </font>with <font color="blue">substantially</font> greater resources may be more     successful in acquiring and developing <font color="blue">surgical <font color="blue">facilities</font></font></td>
    </tr>
    <tr>
      <td>Our optical     <font color="blue">laboratories</font>  and  optical  <font color="blue">products purchasing organization also face</font>     <font color="blue">competition</font> on national, regional and <font color="blue">local levels</font></td>
    </tr>
    <tr>
      <td><font color="blue">Companies </font>in other     <font color="blue"><font color="blue">health care industry</font> segments</font>, including managers of hospital-based medical     <font color="blue">specialties</font> or large group medical practices, may become competitors in     providing  ASCs and surgical equipment as well as <font color="blue">competitive</font> eye care     related services</td>
    </tr>
    <tr>
      <td><font color="blue">Competition </font>for retaining the services of highly qualified     medical, technical and managerial personnel is <font color="blue">significant</font></td>
    </tr>
    <tr>
      <td>In addition to     competing for patients and <font color="blue">physician relationships</font>, ASCs are often required     by Medicare and certain state laws to maintain a written transfer <font color="blue">agreement</font>     with an area hospital</td>
    </tr>
    <tr>
      <td>A transfer <font color="blue">agreement</font> provides that a <font color="blue">hospital will</font>     accept an ASC’s patient in the event of an emergency</td>
    </tr>
    <tr>
      <td>Generally, we have not     <font color="blue">encountered problems</font> obtaining transfer <font color="blue">agreement</font>s from area hospitals</td>
    </tr>
    <tr>
      <td>Recently,  however,  in  limited instances, we have observed hospitals     resisting  entering into transfer <font color="blue">agreement</font>s for what we believe to be     <font color="blue">competitive</font> reasons</td>
    </tr>
    <tr>
      <td>While <font color="blue">there often</font> are <font color="blue">alternatives</font> for ASCs to comply     with federal and state <font color="blue">regulations</font> without a transfer <font color="blue">agreement</font>, <font color="blue">competitive</font>     pressures from hospitals may make it more <font color="blue">difficult</font> and/ or expensive for     our ASCs to maintain their licensure and/or Medicare <font color="blue">certification</font></td>
    </tr>
    <tr>
      <td>Reduced prices and <font color="blue"><font color="blue">reimbursement</font> rates</font> for <font color="blue"><font color="blue">surgical procedures</font> as</font> a result     of <font color="blue">competition</font> or Medicare and other <font color="blue">governmental</font> and <font color="blue">private third party</font>     <font color="blue">payor cost containment efforts could reduce</font> our revenue, <font color="blue">profitability</font> and     <font color="blue">cash flow</font>            <font color="blue">Government </font><font color="blue">sponsored <font color="blue">health care programs</font> accounted</font> for <font color="blue">approximately</font>     39prca of our <font color="blue">consolidated net revenue</font> for the year ended <font color="blue">December </font>31, 2005</td>
    </tr>
    <tr>
      <td>The <font color="blue">health care industry</font> is continuing to experience a <font color="blue">trend toward cost</font>     containment as government and private third-party payors seek to contain     <font color="blue">reimbursement</font>  and  <font color="blue">utilization rates</font> and to <font color="blue">negotiate reduced payment</font>     <font color="blue">schedules with health care providers</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">trends may</font> result in a reduction     <font color="blue">from historical levels</font> in <font color="blue">per patient revenue</font> received by our ASCs</td>
    </tr>
    <tr>
      <td>Changes     in Medicare <font color="blue">payment rates</font> have, in the past, resulted in <font color="blue">reduced payments</font> to     ASCs</td>
    </tr>
    <tr>
      <td>Medicaid and other <font color="blue">governmental</font> and <font color="blue">private insurance payments also</font>     could be affected to the extent that these <font color="blue">insurance companies use payment</font>     <font color="blue">methodologies</font>  <font color="blue">based on</font> Medicare rates, or take <font color="blue">actions independent</font> of     Medicare to revise payment <font color="blue">methodologies</font></td>
    </tr>
    <tr>
      <td>On <font color="blue">December </font>8, 2003, the Medicare Prescription Drug, Improvement, and     <font color="blue">Modernization Act </font>of 2003 (referred to as the Medicare Modernization Act)     was  signed  into  law</td>
    </tr>
    <tr>
      <td>The Medicare <font color="blue">Modernization Act </font><font color="blue">eliminates</font> the     <font color="blue">historical practice</font> of basing ASC <font color="blue">facility</font> fees on cost surveys of ASCs, and     instead requires the Centers for Medicare &amp; Medicaid Services (CMS) to     devise a new <font color="blue">methodology</font> for <font color="blue">establishing</font> ASC <font color="blue">facility</font> payments, and to     implement new <font color="blue"><font color="blue">reimbursement</font> rates</font> <font color="blue">based on</font> the new <font color="blue">methodology</font> between     January 1, 2006 and January 1, 2008</td>
    </tr>
    <tr>
      <td><font color="blue">When CMS </font><font color="blue">eventually implements rebased</font>     rates, payment amounts for <font color="blue">most procedures could</font> change, in some cases     <font color="blue">significant</font>ly</td>
    </tr>
    <tr>
      <td>Additionally, the Medicare <font color="blue">Modernization Act </font>provides that <font color="blue">there shall</font>     be <font color="blue">no inflation update</font> to <font color="blue">Medicare ASC </font>rates during calendar years 2005     through 2009</td>
    </tr>
    <tr>
      <td>The freezing of ASC <font color="blue">payment rates</font>, and any <font color="blue">new rate structure</font>     that CMS may put in place by January 1, 2008, could <font color="blue">adversely</font> affect the     revenues of our business</td>
    </tr>
    <tr>
      <td>We cannot determine at this time what the full     impact of <font color="blue">such rate structures will</font> be</td>
    </tr>
    <tr>
      <td>On  February  8,  2006, the <font color="blue">President </font><font color="blue">signed into law</font> the Deficit     Reduction Act of 2005</td>
    </tr>
    <tr>
      <td>This <font color="blue">legislation</font> requires CMS to limit <font color="blue">Medicare     </font><font color="blue">reimbursement</font>s for <font color="blue"><font color="blue">surgical procedures</font> furnished</font> in ASCs to the <font color="blue">amount paid</font>     to a hospital for the <font color="blue">same service effective</font> for <font color="blue">services furnished on</font> and     after  <font color="blue">January  </font>1,  2007</td>
    </tr>
    <tr>
      <td><font color="blue">Since Medicare </font><font color="blue">currently pays</font> ASCs more than     hospitals for <font color="blue">certain procedures <font color="blue">commonly furnished</font></font> in our <font color="blue">facilities</font>, this     change, when implemented, will have the effect of reducing <font color="blue">reimbursement</font> for     <font color="blue">certain services furnished</font> in our <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>This change, when implemented,     <font color="blue">will <font color="blue">negatively</font> impact</font> our business</td>
    </tr>
    <tr>
      <td><font color="blue">Considering </font>the procedures performed in     our ASCs in 2005 and prior years, the most <font color="blue">significant</font> impact to us from     this <font color="blue">legislation</font> will be the reduction <font color="blue">in the Medicare </font><font color="blue">facility</font> fee for the     after-cataract  <font color="blue">laser surgery procedure which</font> is <font color="blue">also known as</font> the YAG     procedure</td>
    </tr>
    <tr>
      <td>Based on the number of YAG procedures performed in our ASCs in     2005, we estimate that the reduction <font color="blue">in the Medicare </font><font color="blue">facility</font> fee paid for     these <font color="blue">procedures would</font> have resulted in a reduction of <font color="blue">approximately</font> dlra1dtta0     million  to  dlra1dtta2 million in net revenue, or 1dtta6prca to 2dtta0prca of our total     <font color="blue">surgical <font color="blue">facilities</font></font> net revenue for 2005</td>
    </tr>
    <tr>
      <td>This <font color="blue">would equate</font> to an estimated     <font color="blue">negative impact</font> in <font color="blue">earnings per</font> share of between dlra0dtta01 and dlra0dtta02</td>
    </tr>
    <tr>
      <td>To the     extent that other payors, <font color="blue">governmental</font> and private, adopt this practice, the     impact could be greater</td>
    </tr>
    <tr>
      <td>Under current <font color="blue">regulations</font>, ASC Covered Procedures, ie, those for     which  a  <font color="blue">facility</font>  fee is <font color="blue">provided by</font> the Medicare program, are those     procedures  <font color="blue">specifically approved by</font> CMS CMS develops and maintains a     listing of <font color="blue">ASC Covered Procedures </font>(<font color="blue">defined by</font> HCPCS Code)</td>
    </tr>
    <tr>
      <td>A <font color="blue">facility</font> fee is     <font color="blue">available only</font> for <font color="blue">listed procedure codes</font></td>
    </tr>
    <tr>
      <td>CMS is required by law to     update the                                         15     ______________________________________________________________________       list of <font color="blue">ASC Covered Procedures </font>every two (2) years</td>
    </tr>
    <tr>
      <td>CMS has disregarded this     <font color="blue">requirement</font>  in  many years</td>
    </tr>
    <tr>
      <td>There is a substantial risk that CMS will     <font color="blue">occasionally disregard</font> this statutory <font color="blue">requirement</font>, and not update the list     of <font color="blue">ASC Covered Procedures </font>as required by law</td>
    </tr>
    <tr>
      <td><font color="blue">On November </font>26, 2004, CMS proposed to delete 100     procedures  from  the  list  of ASC Covered Procedures, including many     procedures  which are <font color="blue">commonly furnished</font> in ASC settings</td>
    </tr>
    <tr>
      <td><font color="blue">Although CMS     </font><font color="blue">ultimately decide</font>d in May 2005 to <font color="blue">delete only five</font> of the proposed 100     procedures, CMS <font color="blue">could again propose</font> and <font color="blue">ultimately decide</font> to <font color="blue">substantially</font>     reduce the number of procedures for which Medicare will pay an ASC <font color="blue">facility</font>     fee, a change <font color="blue">which could affect</font> the <font color="blue">financial viability</font> of our business</td>
    </tr>
    <tr>
      <td>To     the extent that any procedures performed at our ASCs are <font color="blue">deleted from</font> the     list of ASC Covered Procedures, it <font color="blue">could <font color="blue">negatively</font></font> and <font color="blue">materially affect</font>     our business</td>
    </tr>
    <tr>
      <td><font color="blue">Considerable </font><font color="blue">uncertainty surrounds</font> the <font color="blue">future determination</font> of <font color="blue">Medicare     </font><font color="blue">reimbursement</font> levels for <font color="blue">ambulatory surgical services</font></td>
    </tr>
    <tr>
      <td>Services <font color="blue">reimbursable</font>     under the Medicare program are subject to <font color="blue">legislative</font> change, <font color="blue">administrative</font>     rulings, <font color="blue">interpretation</font>s, discretion, <font color="blue">governmental</font> funding restrictions and     <font color="blue">requirement</font>s for <font color="blue">utilization review</font></td>
    </tr>
    <tr>
      <td>Such matters, as well as more general     <font color="blue">governmental</font> budgetary concerns, may <font color="blue">significant</font>ly reduce payments made to     ASCs under this program, and there can be no assurance that future <font color="blue">Medicare     </font><font color="blue">payment rates</font> will be sufficient to cover the costs of, or <font color="blue">cost increases</font>     in, <font color="blue">providing services</font> to Medicare patients</td>
    </tr>
    <tr>
      <td>Revenue from <font color="blue">laser vision</font> <font color="blue">correction</font> procedures comprised <font color="blue">approximately</font>     7prca of our <font color="blue">surgical <font color="blue">facilities</font></font> net revenue for the year ended <font color="blue">December </font>31,     2005</td>
    </tr>
    <tr>
      <td>The market for providing <font color="blue">laser vision</font> <font color="blue">correction</font> and other refractive     <font color="blue">surgery procedures continues</font> to be highly <font color="blue">competitive</font></td>
    </tr>
    <tr>
      <td>This <font color="blue">competitive</font>ness     has resulted in many of our competitors offering <font color="blue">laser vision</font> <font color="blue">correction</font> or     other <font color="blue">refractive surgery services at lower prices than</font> the prices we charge</td>
    </tr>
    <tr>
      <td>If price <font color="blue">competition</font> continues, however, we may choose or be forced to lower     the <font color="blue">facility</font> fees we charge in our <font color="blue">surgical <font color="blue">facilities</font></font></td>
    </tr>
    <tr>
      <td>If we lower our     fees, we could experience <font color="blue">reductions</font> in our revenue, <font color="blue">profitability</font> and cash     flow</td>
    </tr>
    <tr>
      <td>As we develop and acquire more multi-specialty ASCs, we anticipate that     the  percentage  of  our  <font color="blue">surgical <font color="blue">facilities</font></font> net <font color="blue">revenue derived from</font>     <font color="blue">governmental</font> payors such as Medicare will decrease while <font color="blue">reimbursement</font>s from     <font color="blue">private third party</font> payors will increase</td>
    </tr>
    <tr>
      <td>Given this changing payor mix, our     <font color="blue">success will depend on</font> our ability to negotiate favorable <font color="blue">contracts with</font>     <font color="blue">private third party</font> payors</td>
    </tr>
    <tr>
      <td>Even though our <font color="blue">relative dependence on</font> <font color="blue">Medicare     </font><font color="blue">reimbursement</font>s may decrease, our revenue from <font color="blue">private third party</font> payors     could be <font color="blue"><font color="blue">negatively</font> affected by</font> any adverse Medicare changes because many     <font color="blue">private third party</font> payors tie their <font color="blue">reimbursement</font> levels to Medicare rates</td>
    </tr>
    <tr>
      <td>Our revenue and <font color="blue">profitability</font> could decrease if we are unable to maintain     positive <font color="blue">relationships with</font> the physicians who perform <font color="blue">surgical procedures</font>     at our <font color="blue">ASCs        </font>     The success of our business <font color="blue">depends on</font> our <font color="blue">relationship with</font>, and the     success and efforts of, the physicians who perform <font color="blue"><font color="blue">surgical procedures</font> at</font>     our  ASCs</td>
    </tr>
    <tr>
      <td>Our  net  revenue  and  <font color="blue">profitability</font> would decline if our     <font color="blue">relationship with</font> key physicians deteriorated or those <font color="blue">physicians reduced</font> or     eliminated their use of our ASCs</td>
    </tr>
    <tr>
      <td>In addition, co-owning ASCs <font color="blue">with physicians may</font> create <font color="blue">additional</font>     <font color="blue"><font color="blue">regulatory</font> risk</font></td>
    </tr>
    <tr>
      <td>”         <font color="blue">Regulation </font>of the construction, <font color="blue">acquisition</font> or expansion of ASCs could     <font color="blue">prevent us from</font> developing, acquiring, expanding or relocating <font color="blue">facilities</font>            Most states require licenses to own and operate ASCs, and some states     require a <font color="blue">certificate</font> of need or CON to construct or modify <font color="blue">an ASC Several     </font>states recently have <font color="blue">been revising licensure</font> and CON laws in a manner that     makes it more <font color="blue">difficult</font> to develop or relocate ASCs</td>
    </tr>
    <tr>
      <td>If we are unable to     procure the <font color="blue">appropriate</font> state <font color="blue">licensure approvals</font>, or if we are unable to     obtain a CON in states with CON laws, then we may not be able to acquire or     construct a sufficient number of ASCs, or to expand the scope of services     offered in our existing ASCs, to achieve our <font color="blue">growth strategy</font></td>
    </tr>
    <tr>
      <td><font color="blue">Procuring     </font>these <font color="blue">approvals could</font> take considerable time, effort and expense, and may     result in delays in <font color="blue">opening new</font> or modified <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>Moreover, if we are     unable to maintain good <font color="blue">relations with</font> the                                         16     ______________________________________________________________________        landlords of our ASCs, we may be forced to relocate a <font color="blue">facility</font> from time to     time</td>
    </tr>
    <tr>
      <td>If we are forced to relocate a <font color="blue">facility</font>, we may incur substantial     costs  in  building  out and furnishing our <font color="blue">new location</font></td>
    </tr>
    <tr>
      <td>In addition,     <font color="blue">depending on</font> the state, we may also have <font color="blue">difficult</font>y obtaining the <font color="blue">necessary</font>     state licensure and CON approvals to relocate the <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>”         Changes in the <font color="blue">interpretation</font> of <font color="blue">existing laws</font> and <font color="blue">regulations</font>, or     adoption of new laws or <font color="blue">regulations</font>, governing our business <font color="blue">operations</font>,     including physician use and/or ownership of ASCs, could result in penalties     to us, require us to incur <font color="blue">significant</font> expenditures, or force us to make     changes to our business <font color="blue">operations</font>            We are subject to extensive <font color="blue">government regulation</font> and <font color="blue">supervision under</font>     federal,  state and <font color="blue">local laws</font> and <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>Many of these laws and     <font color="blue">regulations</font>  are  subject  to  varying <font color="blue">interpretation</font>s, and courts and     <font color="blue">regulatory</font>  <font color="blue">authorities</font> <font color="blue">generally</font> have provided limited <font color="blue">clarification</font></td>
    </tr>
    <tr>
      <td>Moreover, state and <font color="blue">local laws</font> and <font color="blue">interpretation</font>s vary from <font color="blue">jurisdiction</font> to     <font color="blue">jurisdiction</font></td>
    </tr>
    <tr>
      <td>As a result, we may not always be able to <font color="blue">accurately</font> predict     <font color="blue">interpretation</font>s of applicable law, and federal and state <font color="blue">authorities</font> could     challenge some of our <font color="blue">activities</font>, including our co-ownership of ASCs with     physicians and other investors</td>
    </tr>
    <tr>
      <td>If any of our <font color="blue">activities</font> are challenged, we     may have to divert substantial time, attention and <font color="blue">resources from running</font>     our business to defend our <font color="blue">activities</font> against these <font color="blue">challenges</font>, <font color="blue">regardless</font>     of their merit</td>
    </tr>
    <tr>
      <td>If we do not <font color="blue">successfully</font> defend these <font color="blue">challenges</font>, we may     face a variety of <font color="blue">adverse consequences</font>, including:       * loss of use of our ASCs;       * losing our <font color="blue">eligibility</font> to <font color="blue">participate</font> in <font color="blue">Medicare or Medicaid </font>or losing         other <font color="blue">contracting</font> privileges; or       * in some instances, civil or criminal fines or penalties</td>
    </tr>
    <tr>
      <td>Any  of these results <font color="blue">could impair</font> our sources of revenue and our     <font color="blue">profitability</font> and limit our ability to grow our business</td>
    </tr>
    <tr>
      <td>For example, the federal anti-kickback statute prohibits the knowing     and  willful  solicitation, receipt, offer or payment of any direct or     <font color="blue">indirect remuneration</font> in return for the referral of patients or the ordering     or purchasing of items or <font color="blue">services payable under</font> Medicare, Medicaid or other     federal  <font color="blue">health care programs</font></td>
    </tr>
    <tr>
      <td>This statute is very broad and <font color="blue"><font color="blue">Congress </font>    </font>directed the <font color="blue">Department of Health and Human Services </font>to develop <font color="blue">regulatory</font>     <font color="blue">exceptions</font>, known as <font color="blue">safe harbor</font>s, to the statute’s referral prohibitions</td>
    </tr>
    <tr>
      <td>While we have attempted to structure the ownership and operation of our ASCs     within a <font color="blue">safe harbor</font>, we do not satisfy all of the <font color="blue">requirement</font>s</td>
    </tr>
    <tr>
      <td><font color="blue">Because     </font>there is no legal <font color="blue">requirement</font> that <font color="blue">relationships fit within</font> a <font color="blue">safe harbor</font>, a     business <font color="blue">arrangement</font> that does not <font color="blue">comply with</font> the <font color="blue">safe harbor</font>, or for which     a <font color="blue">safe harbor</font> does not exist, does not <font color="blue">necessarily violate</font> the anti-kickback     statute</td>
    </tr>
    <tr>
      <td>Presently, despite the fact that we do not fit within a <font color="blue">safe harbor</font>, we     believe  that  our  ownership  and operation of ASCs <font color="blue">complies with</font> the     anti-kickback statute</td>
    </tr>
    <tr>
      <td>However, existing <font color="blue">interpretation</font>s or <font color="blue">enforcement</font> of     the federal anti-kickback statute or other <font color="blue">applicable federal</font> or state laws     and <font color="blue">regulations</font> could change</td>
    </tr>
    <tr>
      <td>If so, violations of the anti-kickback statute     or other laws may result in substantial civil and <font color="blue">criminal penalties</font> and     <font color="blue">exclusion from participation</font> in Medicare, Medicaid and other <font color="blue">federally</font>     <font color="blue">funded programs</font></td>
    </tr>
    <tr>
      <td>In addition, there also is a material risk that Congress, CMS or the     states <font color="blue">could revise physician ownership</font> and <font color="blue">referral laws</font> in a manner that     <font color="blue">could prohibit</font> or <font color="blue">limit physician ownership</font> of ASCs</td>
    </tr>
    <tr>
      <td>In <font color="blue">December </font>2003,     <font color="blue">Congress </font>enacted <font color="blue">legislation</font> imposing an 18-month <font color="blue">moratorium</font> on physician     referrals to <font color="blue">certain categories</font> of hospitals, ie, those <font color="blue">classified as</font>     “specialty hospitals” under the law, if the physician has an ownership     interest in the entity</td>
    </tr>
    <tr>
      <td>This <font color="blue"><font color="blue">moratorium</font> expired</font> in June 2005</td>
    </tr>
    <tr>
      <td><font color="blue">Congress </font>and     CMS are both considering extending or <font color="blue">possibly expanding</font> the scope of the     <font color="blue">moratorium</font></td>
    </tr>
    <tr>
      <td>Actions by either <font color="blue">Congress </font>or CMS potentially <font color="blue">could prohibit</font> or     limit  physician  ownership  of ASCs</td>
    </tr>
    <tr>
      <td>Additionally, several states are     considering <font color="blue">limits on physician ownership</font> in and referrals to specialty     hospitals,  and a few are considering similar <font color="blue">limitations on physician</font>     ownership in and referrals to ASCs</td>
    </tr>
    <tr>
      <td>To the extent that Congress, CMS or any     of the states act to prohibit or <font color="blue">limit physician ownership</font> of ASCs, the     <font color="blue">investment</font> <font color="blue">arrangement</font>s in our ASCs could be affected</td>
    </tr>
    <tr>
      <td>17     ______________________________________________________________________            Our  limited <font color="blue"><font color="blue">liability</font> company</font> <font color="blue">agreement</font>s and limited <font color="blue">partnership</font>     <font color="blue">agreement</font>s provide that if <font color="blue">certain laws</font> and <font color="blue">regulations</font> change, or the     <font color="blue">interpretation</font> and/or <font color="blue">enforcement</font> of such laws and <font color="blue">regulations</font> change, we     may have to purchase some or all of the <font color="blue"><font color="blue">equity interest</font>s</font> in our ASCs owned     <font color="blue">by physicians</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">regulatory</font> changes that <font color="blue">could trigger</font> this repurchase     include it becoming: (i) illegal for a physician to own an <font color="blue">equity interest</font>     in one of our ASCs; (ii) illegal for physician-owners in our ASCs to refer     Medicare or other patients to the <font color="blue">facility</font>; or (iii) <font color="blue">substantially</font> likely     that the receipt by physician-owners of <font color="blue">cash distributions from</font> the limited     <font color="blue"><font color="blue">liability</font> company</font> or <font color="blue">partnership</font> will be illegal</td>
    </tr>
    <tr>
      <td>The cost of <font color="blue">repurchasing</font>     these <font color="blue"><font color="blue">equity interest</font>s</font> would be substantial</td>
    </tr>
    <tr>
      <td>We may not have sufficient     <font color="blue">capital resources</font> to fund these <font color="blue">obligations</font>, and it may trigger the need to     <font color="blue">procure <font color="blue">additional</font> equity financing</font></td>
    </tr>
    <tr>
      <td>While we     attempt to structure these purchase <font color="blue">obligations</font> as favorable as possible to     us, the triggering of these <font color="blue">obligations</font> could have a <font color="blue">significant</font>ly negative     effect on our <font color="blue">financial condition</font> and business prospects</td>
    </tr>
    <tr>
      <td>Furthermore, CMS may revise the Medicare <font color="blue">conditions</font> for coverage of ASC     services</td>
    </tr>
    <tr>
      <td>Our Medicare-certified ASCs are required to <font color="blue">comply with</font> a series     of <font color="blue">regulatory</font> <font color="blue">obligations</font> in order to <font color="blue">qualify services furnished</font> in those     <font color="blue">facilities</font> for Medicare <font color="blue">reimbursement</font></td>
    </tr>
    <tr>
      <td>CMS has not revised the <font color="blue">Medicare     </font><font color="blue">regulatory</font> <font color="blue">conditions</font> for coverage in many years, but has in <font color="blue">recent years</font>     indicated its intent to update these <font color="blue">requirement</font>s through notice and comment     rulemaking</td>
    </tr>
    <tr>
      <td>It is our <font color="blue">expectation</font> that our <font color="blue">facilities</font> and <font color="blue">operations</font> could     be modified as <font color="blue">necessary</font> to <font color="blue">comply with</font> whatever new <font color="blue">conditions</font> might be     established</td>
    </tr>
    <tr>
      <td>However, bringing our <font color="blue">facilities</font> and <font color="blue">operations</font> into compliance     <font color="blue">could involve</font> substantial costs to the company</td>
    </tr>
    <tr>
      <td>Moreover, it is possible     that our <font color="blue">facilities</font> and <font color="blue">operations</font> could not be <font color="blue">revised sufficiently</font> to be     in <font color="blue"><font color="blue">compliance with</font> new</font> Medicare <font color="blue">conditions</font>, in which case some or all of our     ASCs may be forced to <font color="blue">disenroll from</font> the Medicare program</td>
    </tr>
    <tr>
      <td>Many <font color="blue">governmental</font>     and  private  payors  require Medicare <font color="blue">certification</font> as a condition to     <font color="blue">participate</font> in their payment plans</td>
    </tr>
    <tr>
      <td>Any ASC not enrolled in Medicare may     likewise be <font color="blue">precluded from enrolling</font> in other <font color="blue">governmental</font> and <font color="blue">private payor</font>     plans</td>
    </tr>
    <tr>
      <td>Such <font color="blue">exclusion would</font> have a material negative effect on our business</td>
    </tr>
    <tr>
      <td>The nature of being <font color="blue">actively involved</font> in acquiring ASCs could subject us     to potential claims and material <font color="blue">liabilities</font> relating to these <font color="blue">businesses</font>            Although we conduct extensive <font color="blue">due diligence prior</font> to acquiring an ASC     and are <font color="blue">generally</font> indemnified by the sellers, our <font color="blue"><font color="blue">acquisition</font>s</font> could subject     us  to  claims, suits or <font color="blue">liabilities</font> relating to unknown or <font color="blue">contingent</font>     <font color="blue">liabilities</font> or from <font color="blue">incidents</font> occurring prior to our <font color="blue">acquisition</font> of the     <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>If we incur these <font color="blue">liabilities</font> and are not indemnified or insured     for them, our operating results and <font color="blue">financial condition</font> could be <font color="blue">adversely</font>     affected</td>
    </tr>
    <tr>
      <td>If <font color="blue">eye <font color="blue">care <font color="blue"><font color="blue">professional</font>s</font></font></font> and the <font color="blue">general population</font> do not continue to     accept <font color="blue">laser vision</font> <font color="blue">correction</font> and other refractive <font color="blue"><font color="blue">surgical procedures</font> as</font>     <font color="blue">alternatives</font> to <font color="blue">eyeglasses</font> and <font color="blue">contact lenses</font>, a source of our historical     and <font color="blue">future revenue</font> and <font color="blue">earnings growth will</font> be limited             Our <font color="blue">profitability</font> and <font color="blue">growth will depend</font>, in part, <font color="blue">upon continued</font>     acceptance by <font color="blue">eye <font color="blue">care <font color="blue"><font color="blue">professional</font>s</font></font></font> and the <font color="blue">general population</font> of laser     vision <font color="blue">correction</font> and other refractive <font color="blue">surgical procedures</font> in the <font color="blue">US Eye     </font><font color="blue">care <font color="blue"><font color="blue">professional</font>s</font></font> and the <font color="blue">general population</font> might not continue to accept     <font color="blue">laser vision</font> <font color="blue">correction</font> surgery because of the cost of the procedure that,     to date, has <font color="blue">primarily been paid directly by patients</font>, and <font color="blue">concerns about</font>     the  safety  and <font color="blue">effectiveness</font> of <font color="blue">laser vision</font> <font color="blue">correction</font></td>
    </tr>
    <tr>
      <td>If eye care     <font color="blue"><font color="blue">professional</font>s</font> and the <font color="blue">general population</font> do not continue to <font color="blue">accept laser</font>     vision <font color="blue">correction</font> and other refractive <font color="blue">surgical procedures</font>, a source of our     historical and <font color="blue">future revenue</font> and <font color="blue">earnings growth will</font> be limited</td>
    </tr>
    <tr>
      <td>A <font color="blue">significant</font> portion of our revenue from <font color="blue">laser vision</font> <font color="blue">correction</font>     procedures is derived from multi-year laser services <font color="blue">agreement</font>s that we     <font color="blue">negotiated with</font> our <font color="blue">former <font color="blue">affiliated</font> physician practices</font> in <font color="blue"><font color="blue">connection</font> with</font>     the <font color="blue">divestiture</font> of our <font color="blue">physician practice management</font> business</td>
    </tr>
    <tr>
      <td>One of our     largest laser services <font color="blue">agreement</font>s expired in April 2006</td>
    </tr>
    <tr>
      <td>Unless the parties     agree on <font color="blue">extensions</font>, our other laser services <font color="blue">agreement</font>s will be expiring     over the next two years, with the last one expiring <font color="blue">in February </font>2008</td>
    </tr>
    <tr>
      <td>under which we have <font color="blue">procured <font color="blue">excimer lasers</font></font></td>
    </tr>
    <tr>
      <td>We pay <font color="blue">Alcon     </font>monthly <font color="blue">based on</font> the number of procedures performed on <font color="blue">each laser</font>, but are     required to pay for a minimum number of <font color="blue">procedures per year</font> for <font color="blue">each laser</font>,     <font color="blue">regardless</font> of whether the procedure                                         18     ______________________________________________________________________       is performed</td>
    </tr>
    <tr>
      <td>If these <font color="blue">minimum procedure thresholds exceed</font> the actual number     of procedures performed, these <font color="blue">obligations</font> will have an adverse effect on     our <font color="blue">financial condition</font> and operating results</td>
    </tr>
    <tr>
      <td>Our supply <font color="blue">agreement</font> with     Alcon <font color="blue">expires on</font> <font color="blue">December </font>31, 2006</td>
    </tr>
    <tr>
      <td>To the extent we do not extend this     <font color="blue">agreement</font> and we determine that we need to replace those <font color="blue">excimer lasers</font>     furnished to us by Alcon, then we may incur <font color="blue">additional</font> capital costs to     replace these <font color="blue">excimer lasers</font></td>
    </tr>
    <tr>
      <td>Rapid <font color="blue">technological advances may reduce</font> our sources of revenue and our     <font color="blue">profitability</font>             <font color="blue">Adoption </font>of new <font color="blue">technologies</font> that may be comparable or superior to     existing <font color="blue">technologies</font> for surgical equipment could reduce the amount of the     <font color="blue">facility</font> fees we receive <font color="blue">from physicians</font> who use our <font color="blue">surgical <font color="blue">facilities</font></font>, or     the amount of <font color="blue">revenue derived from</font> our laser services <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td><font color="blue">Reduction     </font>of these sources of revenue could decrease our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>In this case,     we  might  have  to expend <font color="blue">significant</font> <font color="blue">capital resources</font> to <font color="blue">deploy new</font>     <font color="blue">technology</font> and related equipment to remain <font color="blue">competitive</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">inability</font> to     <font color="blue">provide access</font> to new and improving <font color="blue">technology</font> could deter physicians from     using our <font color="blue">surgical <font color="blue">facilities</font></font> or equipment</td>
    </tr>
    <tr>
      <td>Loss of the services of <font color="blue">key management</font> personnel could <font color="blue">adversely</font> affect     our business             Our  success  depends, in part, on the services of <font color="blue">key management</font>     personnel,  including <font color="blue">Thomas S Hall </font>our <font color="blue">President </font>and Chief Executive     Officer; Scott T Macomber, our Executive Vice <font color="blue">President </font>and Chief Financial     Officer; and E Michele Vickery, our Executive Vice <font color="blue">President </font>Operations</td>
    </tr>
    <tr>
      <td>However, in light of the role that each of these officers     is expected to play in our <font color="blue">future growth</font>, if we lost the services of any of     these officers, we believe that our business could be <font color="blue"><font color="blue">adversely</font> affected</font></td>
    </tr>
    <tr>
      <td>The nature of our business could subject us to potential malpractice,     <font color="blue">product <font color="blue">liability</font></font> and other claims             The provision of <font color="blue">surgical services entails</font> the potentially <font color="blue">significant</font>     risk  of <font color="blue">physical injury</font> to patients and an <font color="blue">inherent risk</font> of potential     malpractice, <font color="blue">product <font color="blue">liability</font></font> and other similar claims</td>
    </tr>
    <tr>
      <td>Our <font color="blue">insurance may</font>     not be adequate to satisfy claims or <font color="blue">protect us</font> and this <font color="blue">coverage may</font> not     continue to be <font color="blue">available at</font> acceptable costs</td>
    </tr>
    <tr>
      <td>A partially or <font color="blue">completely</font>     uninsured claim <font color="blue">against us could reduce</font> our earnings and working capital</td>
    </tr>
    <tr>
      <td>Our  <font color="blue">insurance policies</font> are <font color="blue">generally</font> renewed on an <font color="blue">annual basis</font></td>
    </tr>
    <tr>
      <td><font color="blue">Although  </font>we  believe we will be able to renew our <font color="blue">current policies</font> or     otherwise obtain <font color="blue">comparable <font color="blue">professional</font> <font color="blue">liability</font> coverage</font>, we have no     control  over  the <font color="blue">potential costs</font> to renew</td>
    </tr>
    <tr>
      <td><font color="blue">Increases </font>in <font color="blue">professional</font>     <font color="blue">liability</font>  and  other  insurance  premiums  will <font color="blue">negatively</font> affect our     <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>If a change in events or <font color="blue">circumstances</font> causes us to write-off a portion of     our <font color="blue">intangible assets</font>, our <font color="blue">total assets</font> could be reduced <font color="blue">significant</font>ly and     we <font color="blue">could incur</font> a substantial charge to earnings            Our assets include <font color="blue"><font color="blue">intangible assets</font> primarily</font> in the form of goodwill</td>
    </tr>
    <tr>
      <td>At  <font color="blue">December </font> 31, 2005, <font color="blue">intangible assets</font> of our continuing <font color="blue">operations</font>     represented <font color="blue">approximately</font> 70prca of <font color="blue">total assets</font> and 116prca of stockholders &amp;apos      equity</td>
    </tr>
    <tr>
      <td>The intangible asset value represents the excess of cost over the     <font color="blue">fair value</font> of the <font color="blue">separately identifiable net assets</font> acquired in <font color="blue">connection</font>     with our <font color="blue"><font color="blue">acquisition</font>s</font> and <font color="blue">affiliations</font></td>
    </tr>
    <tr>
      <td>The value of these <font color="blue">assets may</font> not be     realized</td>
    </tr>
    <tr>
      <td>We regularly, and at least annually, evaluate whether events and     <font color="blue">circumstances</font> have occurred that indicate all or a portion of the carrying     amount  of  the  asset  <font color="blue">may no longer</font> be recoverable, in which case an     <font color="blue">additional</font> charge to earnings may become <font color="blue">necessary</font></td>
    </tr>
    <tr>
      <td>If, in the future, we     determine that our <font color="blue">intangible assets</font> have suffered an <font color="blue">impairment which</font>     requires us to write off a portion of the asset due to a change in events or     <font color="blue">circumstances</font>, this write-off could <font color="blue">significant</font>ly reduce our <font color="blue">total assets</font>     and  we <font color="blue">could incur</font> a substantial charge to earnings, as well as be in     <font color="blue">default under one</font> or more covenants in our credit <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>19     ______________________________________________________________________         <font color="blue">Becoming </font>and remaining compliant with federal <font color="blue">regulations</font> enacted under     the Health Insurance Portability and Accountability Act could require us to     expend <font color="blue">significant</font> resources and capital, and <font color="blue">could impair</font> our <font color="blue">profitability</font>     and limit our ability to grow our business            <font color="blue">Numerous  </font>federal  <font color="blue">regulations</font> have <font color="blue">been <font color="blue">adopted under</font></font> the Health     Insurance Portability and Accountability Act of 1996 (HIPAA)</td>
    </tr>
    <tr>
      <td><font color="blue">Compliance     </font>with HIPAA <font color="blue">regulations</font> governing patient privacy was required by April 14,     2003</td>
    </tr>
    <tr>
      <td>We have <font color="blue">taken actions</font> in an effort to establish our <font color="blue">compliance with</font>     HIPAA’s Privacy <font color="blue">regulations</font>, and we believe that we are in substantial     <font color="blue">compliance with</font> HIPAA’s privacy <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>These actions include having     our ASCs and <font color="blue">affiliated</font> providers implement new HIPAA-compliant policies and     procedures,  <font color="blue">conducting employee</font> HIPAA training, identifying “business     associates” with whom we need to <font color="blue">enter into</font> HIPAA-compliant <font color="blue">contractual</font>     <font color="blue">arrangement</font>s  and  entering  into such <font color="blue">arrangement</font>s, and various other     measures</td>
    </tr>
    <tr>
      <td>Ongoing <font color="blue">implementation</font> and oversight of these <font color="blue">measures involves</font>     <font color="blue">significant</font> time, effort and expense</td>
    </tr>
    <tr>
      <td>Other  federal  <font color="blue">regulations</font>  <font color="blue">adopted under</font> HIPAA require that our     <font color="blue">affiliated</font> providers and us be capable of <font color="blue">conducting certain standardized</font>     <font color="blue">health care <font color="blue">transactions</font></font>, including billing and other claims <font color="blue">transactions</font></td>
    </tr>
    <tr>
      <td>We have undertaken <font color="blue">significant</font> efforts, involving substantial time and     expense,  to  assure that our ASCs and <font color="blue">affiliated</font> providers can submit     <font color="blue">transactions</font> in <font color="blue">compliance with</font> HIPAA We anticipate that continuing time     and  expense  will  be  required  to  maintain  the  ability to submit     HIPAA-compliant <font color="blue">transactions</font>, and to make sure that newly-acquired ASCs can     submit HIPAA-compliant <font color="blue">transactions</font></td>
    </tr>
    <tr>
      <td>In  addition,  <font color="blue">compliance with</font> the HIPAA security <font color="blue">regulations</font> was     required by April 21, 2005</td>
    </tr>
    <tr>
      <td>In general, the security <font color="blue">regulations</font> require     ASCs and other <font color="blue">covered entities</font> to implement reasonable technical, physical     and  <font color="blue">administrative</font>  security  measures  to <font color="blue">safeguard protected health</font>     information maintained, used and disclosed in <font color="blue">electronic</font> form</td>
    </tr>
    <tr>
      <td>We have taken     actions in an effort to establish our <font color="blue">compliance with</font> HIPAA’s security     <font color="blue">regulations</font>, and we believe that we are in substantial <font color="blue">compliance with</font>     HIPAA’s security <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>Ongoing <font color="blue">implementation</font> and oversight of these     <font color="blue">measures involves</font> <font color="blue">significant</font> time, effort and expense</td>
    </tr>
    <tr>
      <td>HIPAA <font color="blue">violations could expose us</font> to <font color="blue">civil penalties</font> of up to dlra25cmam000     per person per year for <font color="blue">each violation</font> or <font color="blue">criminal penalties</font> with fines of     up to dlra250cmam000 and/or up to 10 years in <font color="blue">prison per violation</font></td>
    </tr>
    <tr>
      <td><font color="blue">Risks Relating </font>to our Common Stock         Fluctuations in our quarterly operating results may make it <font color="blue">difficult</font> to     predict our future results of <font color="blue">operations</font> and may cause <font color="blue">volatility</font> in our     stock price             During  2005,  the <font color="blue">market price</font> of our <font color="blue">common stock</font> was volatile,     <font color="blue">fluctuating from</font> a <font color="blue">high trading price</font> of dlra7dtta75 to a <font color="blue">low trading price</font> of     dlra4dtta10 per share</td>
    </tr>
    <tr>
      <td>Our results of <font color="blue">operations</font> have varied and <font color="blue">may continue</font> to     <font color="blue">fluctuate from quarter</font> to quarter</td>
    </tr>
    <tr>
      <td>We have a <font color="blue">high level</font> of fixed operating     costs, including compensation costs, rent and minimum usage <font color="blue">commitment</font>s on     our <font color="blue">excimer lasers</font></td>
    </tr>
    <tr>
      <td>As a result, our <font color="blue">profitability</font> depends to a large degree     on the volume of <font color="blue">surgical procedures</font> performed in, and on our ability to     utilize the <font color="blue">capacity</font> of, our <font color="blue">surgical <font color="blue">facilities</font></font>, as well as the volume of     <font color="blue">surgical procedures</font> performed through our laser services <font color="blue">agreement</font>s</td>
    </tr>
    <tr>
      <td>The timing and degree of <font color="blue">fluctuations</font> in our operating results will     <font color="blue">depend on several factors</font>, including:       * general economic <font color="blue">conditions</font>;       * <font color="blue">decreases</font> in demand for non-emergency procedures due to <font color="blue">severe weather</font>;       * <font color="blue">availability</font> or <font color="blue">sudden loss</font> of the services of physicians who utilize         our <font color="blue">surgical <font color="blue">facilities</font></font>;       * <font color="blue">availability</font> or shortages of surgery-related products and equipment,         including technologically progressive <font color="blue">laser vision</font> <font color="blue">correction</font> equipment;       * the timing and <font color="blue">relative size</font> of <font color="blue"><font color="blue">acquisition</font>s</font>; and       * the recording of gains or losses on the sale of <font color="blue">minority interests</font> in         our ASCs</td>
    </tr>
    <tr>
      <td>These kinds of <font color="blue">fluctuations</font> in quarterly operating results may make it     <font color="blue">difficult</font> for you to assess our future results of <font color="blue">operations</font> and may cause a     decline or <font color="blue">volatility</font> in our stock price</td>
    </tr>
    <tr>
      <td>20     ______________________________________________________________________         Any return on your <font color="blue">investment</font> in our <font color="blue">stock will depend on</font> your ability to     sell our stock at a profit             We have never declared or paid any dividends and our credit <font color="blue">agreement</font>     <font color="blue">prohibits payment</font> of <font color="blue">dividends on</font> our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>We anticipate that we     will not declare <font color="blue">dividends at</font> any time in the <font color="blue">foreseeable future</font></td>
    </tr>
    <tr>
      <td>In addition, the <font color="blue">stock market</font> has, from time to time, experienced     <font color="blue">extreme price</font> and volume <font color="blue">fluctuations</font></td>
    </tr>
    <tr>
      <td>These broad market <font color="blue">fluctuations</font> may     <font color="blue">adversely</font> affect the <font color="blue">market price</font> of our <font color="blue">common stock</font></td>
    </tr>
  </tbody>
</table>